Dr. Leigh Sharpless discusses her paper, "Variation in Endpoints in FDA Medication Approvals: A Review of Acute and Preventive Migraine Medications".
Show References: https://n.neurology.org/content/101/10/e989
https://directory.libsyn.com/episode/index/id/27962343